Clinical Trials Browser

Phase 1 × Solid Tumors × pembrolizumab × Clear all

NCT03313778 2026-03-04

KEYNOTE-603

Phase 1 Active not recruiting

Other solid neoplasm

Solid Tumors

NCT05996445 2024-08-23

A Study of XmAb®662 as Monotherapy or in Combination With Pembrolizumab in Advanced Solid Tumors

Phase 1 Terminated

Other solid neoplasm

Solid Tumors